HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4- formyl- 2- (4- hydroxy- 3- methoxyphenyl)- 5- (2- methoxycarbonyethyl)- 7- methoxy- benzo(b)furan

structure in first source

Also Known As:

ERJT-12

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzofurans: 26
      - 4-formyl-2-(4-hydroxy-3-methoxyphenyl)-5-(2-methoxycarbonyethyl)-7-methoxy-benzo(b)furan: 2

Experts

1.	Cai, Yu-Chen: 2 articles (02/2008 - 09/2006)
2.	Pang, Ji-Yan: 2 articles (02/2008 - 09/2006)
3.	Xian, Li-Jian: 2 articles (02/2008 - 09/2006)
4.	Xu, Zun-Le: 2 articles (02/2008 - 09/2006)
5.	Yang, Hua: 2 articles (02/2008 - 09/2006)
6.	Li, Yong-Qiang: 1 article (02/2008)
7.	Zeng, Zhao-Lei: 1 article (02/2008)

Related Diseases

1.

Neoplasms (Cancer)

02/01/2008 - "MTT assay showed that ERJT-12 inhibited the proliferation of several cancer cell lines including multidrug resistant cells. "
02/01/2008 - "In vitro growth inhibitory effects of ERJT-12 on various cancer cell lines were determined by MTT assay. "
09/01/2006 - "These results suggested that the anti-cancer activity of ERJT-12 is worth further investigation."
09/01/2006 - "Our results demonstrated that ERJT-12 exhibited anti-cancer activity in a variety of tumour cell lines with an IC50 value (concentration resulting in 50% inhibition of cell growth) of 5.75 approximately 17.29 microM. "
02/01/2008 - "ERJT-12 displays potent antiproliferative activity towards cancer cells through suppressing cell cycle proteins, arresting cell cycle at G2/M phase and inducing apoptosis. "

Related Drugs and Biologics

1.	Cell Cycle Proteins